DENTSPLY SIRONA Cash Flow from Investing Activities 2010-2024 | XRAY

DENTSPLY SIRONA annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • DENTSPLY SIRONA cash flow from investing activities for the quarter ending March 31, 2024 was $-0.043B, a 16.22% increase year-over-year.
  • DENTSPLY SIRONA cash flow from investing activities for the twelve months ending March 31, 2024 was $-0.268B, a 26.98% decline year-over-year.
  • DENTSPLY SIRONA annual cash flow from investing activities for 2023 was $-0.089B, a 35.51% decline from 2022.
  • DENTSPLY SIRONA annual cash flow from investing activities for 2022 was $-0.138B, a 61.45% decline from 2021.
  • DENTSPLY SIRONA annual cash flow from investing activities for 2021 was $-0.358B, a 67.63% decline from 2020.
DENTSPLY SIRONA Annual Cash Flow Investing
(Millions of US $)
2023 $-89
2022 $-138
2021 $-358
2020 $-1,106
2019 $-69
2018 $-253
2017 $-286
2016 $60
2015 $-55
2014 $-139
2013 $-260
2012 $-115
2011 $-1,887
2010 $-164
2009 $-53
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.872B $3.965B
DENTSPLY SIRONA Inc. is a global leader in the design, development, manufacture and marketing of dental consumables, dental laboratory products, dental specialty products and consumable medical device products. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. The business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00